ReP USP - Resultado da busca

Artigo de periodico
De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival (2012)
Caires, R. A.; Marques, I. D. B.; Repizo, L. P.; Sato, V. A. H.; Carmo, L. P. F.; Machado, D. J. B.; Paula, F. J. de; Nahas, W. C.; David-Neto, E.
Source: Transplantation Proceedings. Unidade: FM
Subjects: TRANSPLANTE DE RIM, DOENÇAS VASCULARES (DIAGNÓSTICO), SEGUIMENTOS, IMUNOSSUPRESSÃO, IMUNOFLUORESCÊNCIA, TROMBOSE, DOENÇAS VASCULARES (FISIOPATOLOGIA;TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAIRES, R. A. et al. De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival. Transplantation Proceedings, v. 44, n. 8, p. 2388-2390, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.transproceed.2012.07.039. Acesso em: 02 nov. 2024.
APA
Caires, R. A., Marques, I. D. B., Repizo, L. P., Sato, V. A. H., Carmo, L. P. F., Machado, D. J. B., et al. (2012). De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival. Transplantation Proceedings, 44( 8), 2388-2390. doi:10.1016/j.transproceed.2012.07.039
NLM
Caires RA, Marques IDB, Repizo LP, Sato VAH, Carmo LPF, Machado DJB, Paula FJ de, Nahas WC, David-Neto E. De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival [Internet]. Transplantation Proceedings. 2012 ; 44( 8): 2388-2390.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.transproceed.2012.07.039
Vancouver
Caires RA, Marques IDB, Repizo LP, Sato VAH, Carmo LPF, Machado DJB, Paula FJ de, Nahas WC, David-Neto E. De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival [Internet]. Transplantation Proceedings. 2012 ; 44( 8): 2388-2390.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.transproceed.2012.07.039
Artigo de periodico
Comparison of the Safety and Efficacy of Cyclosporine Minimization Versus Cyclosporine Elimination in De Novo Renal Allograft Patients Receiving Sirolimus (2010)
Tedesco-Silva, H.; Duro Garcia, V.; Contieri, F. L. C.; Carvalho, D. De Boni Monteiro de; Noronha, Irene de Lourdes; Gonçalves, R. T.; Jota de Paula, F.; Abbud-Filho, M.; Manfro, R. C.; David-Neto, E.; Alfieri, F.; Ikehara, E.; Jiang, Q.; Tai, S. S.; Medina-Pestana, J. O.
Source: Transplantation Proceedings. Unidade: FM
Subjects: TRANSPLANTE DE RIM, TERAPIA COMBINADA, IMUNOTERAPIA, CICLOSPORINAS (EFICIÊNCIA;CONCENTRAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEDESCO-SILVA, H. et al. Comparison of the Safety and Efficacy of Cyclosporine Minimization Versus Cyclosporine Elimination in De Novo Renal Allograft Patients Receiving Sirolimus. Transplantation Proceedings, v. 42, n. 5, p. 1659-1666, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.transproceed.2010.02.083. Acesso em: 02 nov. 2024.
APA
Tedesco-Silva, H., Duro Garcia, V., Contieri, F. L. C., Carvalho, D. D. B. M. de, Noronha, I. de L., Gonçalves, R. T., et al. (2010). Comparison of the Safety and Efficacy of Cyclosporine Minimization Versus Cyclosporine Elimination in De Novo Renal Allograft Patients Receiving Sirolimus. Transplantation Proceedings, 42( 5), 1659-1666. doi:10.1016/j.transproceed.2010.02.083
NLM
Tedesco-Silva H, Duro Garcia V, Contieri FLC, Carvalho DDBM de, Noronha I de L, Gonçalves RT, Jota de Paula F, Abbud-Filho M, Manfro RC, David-Neto E, Alfieri F, Ikehara E, Jiang Q, Tai SS, Medina-Pestana JO. Comparison of the Safety and Efficacy of Cyclosporine Minimization Versus Cyclosporine Elimination in De Novo Renal Allograft Patients Receiving Sirolimus [Internet]. Transplantation Proceedings. 2010 ; 42( 5): 1659-1666.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.transproceed.2010.02.083
Vancouver
Tedesco-Silva H, Duro Garcia V, Contieri FLC, Carvalho DDBM de, Noronha I de L, Gonçalves RT, Jota de Paula F, Abbud-Filho M, Manfro RC, David-Neto E, Alfieri F, Ikehara E, Jiang Q, Tai SS, Medina-Pestana JO. Comparison of the Safety and Efficacy of Cyclosporine Minimization Versus Cyclosporine Elimination in De Novo Renal Allograft Patients Receiving Sirolimus [Internet]. Transplantation Proceedings. 2010 ; 42( 5): 1659-1666.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.transproceed.2010.02.083
Trabalho de evento-resumo periodico
Renal Transplantation Using Living Donors With A Positive Crossmatch: Can We Predict Efficacy of Desensitization With Ivig By An "in Vitro" Test? (2004)
Castro, M. C. R.; Panajotopoulos, N.; Araújo, L. M. P.; Rodrigues, H.; Maciel, R.; Ronda, C.; Viggiani, C.; Nahas, W. C.; David-Neto, E.; Ianhez, L. E.; Kalil Filho, J.; Glotz, D.
Source: Transplantation. Conference titles: International Congress of the Transplantation Society. Unidade: FM
Subjects: TRANSPLANTE DE RIM, ANTICORPOS, DOAÇÃO ENTRE VIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, M. C. R. et al. Renal Transplantation Using Living Donors With A Positive Crossmatch: Can We Predict Efficacy of Desensitization With Ivig By An "in Vitro" Test?. Transplantation. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2004
APA
Castro, M. C. R., Panajotopoulos, N., Araújo, L. M. P., Rodrigues, H., Maciel, R., Ronda, C., et al. (2004). Renal Transplantation Using Living Donors With A Positive Crossmatch: Can We Predict Efficacy of Desensitization With Ivig By An "in Vitro" Test? Transplantation. Baltimore: Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro MCR, Panajotopoulos N, Araújo LMP, Rodrigues H, Maciel R, Ronda C, Viggiani C, Nahas WC, David-Neto E, Ianhez LE, Kalil Filho J, Glotz D. Renal Transplantation Using Living Donors With A Positive Crossmatch: Can We Predict Efficacy of Desensitization With Ivig By An "in Vitro" Test? Transplantation. 2004 ; 78( 2): 258.[citado 2024 nov. 02 ]
Vancouver
Castro MCR, Panajotopoulos N, Araújo LMP, Rodrigues H, Maciel R, Ronda C, Viggiani C, Nahas WC, David-Neto E, Ianhez LE, Kalil Filho J, Glotz D. Renal Transplantation Using Living Donors With A Positive Crossmatch: Can We Predict Efficacy of Desensitization With Ivig By An "in Vitro" Test? Transplantation. 2004 ; 78( 2): 258.[citado 2024 nov. 02 ]
Trabalho de evento-resumo periodico
Living unrelated donor (LURD) in Kidney transplantation is better than cadaver an similar to one-haplotype living related donor: a retrospective study of a 10-year period (1999)
Castro, M. C. R.; David-Neto, E.; Ianhez, L.; Paula, F. J.; Chocair, P. R.; Azevedo, L.; Fonseca, J.; Galvao, M. M.; Cavalcanti, F.; Mazzuchil, E.; Anatopoulos, I.; Nahas, W.; Arap, Sami; Sabbaga, E.
Source: Journal of the American Society of Nephrology. Conference titles: Annual Meeting and 1999 Renal Week. Unidade: FM
Assunto: CIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, M. C. R. et al. Living unrelated donor (LURD) in Kidney transplantation is better than cadaver an similar to one-haplotype living related donor: a retrospective study of a 10-year period. Journal of the American Society of Nephrology. Florida: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 1999
APA
Castro, M. C. R., David-Neto, E., Ianhez, L., Paula, F. J., Chocair, P. R., Azevedo, L., et al. (1999). Living unrelated donor (LURD) in Kidney transplantation is better than cadaver an similar to one-haplotype living related donor: a retrospective study of a 10-year period. Journal of the American Society of Nephrology. Florida: Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro MCR, David-Neto E, Ianhez L, Paula FJ, Chocair PR, Azevedo L, Fonseca J, Galvao MM, Cavalcanti F, Mazzuchil E, Anatopoulos I, Nahas W, Arap S, Sabbaga E. Living unrelated donor (LURD) in Kidney transplantation is better than cadaver an similar to one-haplotype living related donor: a retrospective study of a 10-year period. Journal of the American Society of Nephrology. 1999 ; 10 722A res. A 3657.[citado 2024 nov. 02 ]
Vancouver
Castro MCR, David-Neto E, Ianhez L, Paula FJ, Chocair PR, Azevedo L, Fonseca J, Galvao MM, Cavalcanti F, Mazzuchil E, Anatopoulos I, Nahas W, Arap S, Sabbaga E. Living unrelated donor (LURD) in Kidney transplantation is better than cadaver an similar to one-haplotype living related donor: a retrospective study of a 10-year period. Journal of the American Society of Nephrology. 1999 ; 10 722A res. A 3657.[citado 2024 nov. 02 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em